Assessment of response of brain metastases to radiotherapy by PET imaging of apoptosis with 18F-ML-10

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 39, Issue 9, 2012, Pages 1400-1408

  Allen, Aaron M ^a,b   Ben Ami, Miri ^c   Reshef, Ayelet ^c   Steinmetz, Adam ^a,b   Kundel, Yulia ^a,b   Inbar, Edna ^a,b   Djaldetti, Ruth ^a,b   Davidson, Tal ^c   Fenig, Eyal ^a,b   Ziv, Ilan ^a,b,c  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c Aposense Ltd   (Israel)

Author keywords

Apoptosis; Brain metastases; Positron emission tomography; Response assessment; Whole brain radiation therapy

Indexed keywords

2 (5 FLUOROPENTYL) 2 METHYLMALONIC ACID F 18; ML 10; TRACER; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; BRAIN METASTASIS; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG SAFETY; DRUG UPTAKE; FEMALE; HUMAN; MALE; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; RADIATION DOSE; TREATMENT RESPONSE;

ADULT; AGED; APOPTOSIS; BIOLOGICAL TRANSPORT; BRAIN NEOPLASMS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; METHYLMALONIC ACID; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOACTIVE TRACERS; SAFETY; SIGNAL-TO-NOISE RATIO; TREATMENT OUTCOME;

EID: 84865656104     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-012-2150-8     Document Type: Article

References (29)

1. EC Kaal CG Niel CJ Vecht 2005 Therapeutic management of brain metastasis Lancet Neurol 4 5 289 298 15847842 10.1016/S1474-4422(05)70072-7
2. G Welzel K Fleckenstein J Schaefer B Hermann U Kraus-Tiefenbacher SK Mai, et al. 2008 Memory function before and after whole brain radiotherapy in patients with and without brain metastases Int J Radiat Oncol Biol Phys 72 5 1311 1318 18448270 10.1016/j.ijrobp.2008.03.009
3. DW Andrews CB Scott PW Sperduto AE Flanders LE Gaspar MC Schell, et al. 2004 Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial Lancet 363 9422 1665 1672 15158627 10.1016/S0140-6736(04)16250-8
4. H Aoyama H Shirato M Tago K Nakagawa T Toyoda K Hatano, et al. 2006 Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial JAMA 295 21 2483 2491 16757720 10.1001/jama.295.21.2483 1:CAS:528:DC%2BD28XlsV2ltbo%3D
5. RA Patchell PA Tibbs JW Walsh RJ Dempsey Y Maruyama RJ Kryscio, et al. 1990 A randomized trial of surgery in the treatment of single metastases to the brain N Engl J Med 322 8 494 500 2405271 10.1056/NEJM199002223220802 1:STN:280:DyaK3c7js1OlsQ%3D%3D
6. MP Mehta NA Paleologos T Mikkelsen PD Robinson M Ammirati DW Andrews, et al. 2010 The role of chemotherapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline J Neurooncol 96 1 71 83 19960229 10.1007/s11060-009-0062-7
7. MP Mehta MN Tsao TJ Whelan DE Morris JA Hayman JC Flickinger, et al. 2005 The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases Int J Radiat Oncol Biol Phys 63 1 37 46 16111570 10.1016/j.ijrobp.2005.05.023
8. J Li SM Bentzen M Renschler MP Mehta 2007 Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function J Clin Oncol 25 10 1260 1266 17401015 10.1200/JCO.2006.09.2536
9. S Maddika SR Ande S Panigrahi T Paranjothy K Weglarczyk A Zuse, et al. 2007 Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy Drug Resist Updat 10 1-2 13 29 17303468 10.1016/j.drup.2007.01.003 1:CAS:528:DC%2BD2sXkslahsbw%3D
10. JA Call SG Eckhardt DR Camidge 2008 Targeted manipulation of apoptosis in cancer treatment Lancet Oncol 9 10 1002 1011 18760670 10.1016/S1470-2045(08) 70209-2 1:CAS:528:DC%2BD1cXhtFOmurrI
11. J Meiler M Schuler 2006 Therapeutic targeting of apoptotic pathways in cancer Curr Drug Targets 7 10 1361 1369 17073598 10.2174/138945006778559175 1:CAS:528:DC%2BD28XhtVCjsbfK
12. W Hu JJ Kavanagh 2003 Anticancer therapy targeting the apoptotic pathway Lancet Oncol 4 12 721 729 14662428 10.1016/S1470-2045(03)01277-4 1:CAS:528:DC%2BD3sXps1OgsL0%3D
13. JL Fernandez-Luna 2007 Apoptosis regulators as targets for cancer therapy Clin Transl Oncol 9 9 555 562 17921102 10.1007/s12094-007-0103-7 1:CAS:528:DC%2BD1cXlslahtg%3D%3D
14. RE Meyn L Milas KK Ang 2009 The role of apoptosis in radiation oncology Int J Radiat Biol 85 2 107 115 19280463 10.1080/09553000802662595 1:CAS:528:DC%2BD1MXlslSmsLk%3D
15. A Cohen A Shirvan G Levin H Grimberg A Reshef I Ziv 2009 From the Gla domain to a novel small-molecule detector of apoptosis Cell Res 19 5 625 637 19223854 10.1038/cr.2009.17 1:CAS:528:DC%2BD1MXlsFKrtLo%3D
16. J Hoglund A Shirvan G Antoni SA Gustavsson B Langstrom A Ringheim, et al. 2011 18F-ML-10, a PET tracer for apoptosis: first human study J Nucl Med 52 5 720 725 21498526 10.2967/jnumed.110.081786
17. A Reshef A Shirvan RN Waterhouse H Grimberg G Levin A Cohen, et al. 2008 Molecular imaging of neurovascular cell death in experimental cerebral stroke by PET J Nucl Med 49 9 1520 1528 18703595 10.2967/jnumed.107.043919 1:CAS:528:DC%2BD1cXhtFOisr7J
18. A Reshef A Shirvan A Akselrod-Ballin A Wall I Ziv 2010 Small-molecule biomarkers for clinical PET imaging of apoptosis J Nucl Med 51 6 837 840 20484422 10.2967/jnumed.109.063917 1:CAS:528:DC%2BC3cXosl2ksLY%3D
19. CJ Galban TL Chenevert CR Meyer C Tsien TS Lawrence DA Hamstra, et al. 2011 Prospective analysis of parametric response map-derived MRI biomarkers: identification of early and distinct glioma response patterns not predicted by standard radiographic assessment Clin Cancer Res 17 14 4751 4760 21527563 10.1158/1078-0432.CCR-10-2098
20. TC Kwee CJ Galban C Tsien L Junck PC Sundgren MK Ivancevic, et al. 2010 Comparison of apparent diffusion coefficients and distributed diffusion coefficients in high-grade gliomas J Magn Reson Imaging 31 3 531 537 20187193 10.1002/jmri.22070
21. B Ma CR Meyer MD Pickles TL Chenevert PH Bland CJ Galban, et al. 2009 Voxel-by-voxel functional diffusion mapping for early evaluation of breast cancer treatment Inf Process Med Imaging 21 276 287 19694270 10.1007/978-3-642-02498-6-23
22. Moffat BA, Chenevert TL, Lawrence TS, Meyer CR, Johnson TD, Dong Q, et al. Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci U S A. 2005;102(15):5524-9.
23. R Aloya A Shirvan H Grimberg A Reshef G Levin D Kidron, et al. 2006 Molecular imaging of cell death in vivo by a novel small molecule probe Apoptosis 11 12 2089 2101 17051335 10.1007/s10495-006-0282-7
24. FJ Hoebers M Kartachova J de Bois MW van den Brekel H van Tinteren M van Herk, et al. 2008 99mTc Hynic-rh-Annexin V scintigraphy for in vivo imaging of apoptosis in patients with head and neck cancer treated with chemoradiotherapy Eur J Nucl Med Mol Imaging 35 3 509 518 17994297 10.1007/s00259-007-0624-x 1:CAS:528:DC%2BD1cXjvFOgt74%3D
25. KJ Yagle JF Eary JF Tait JR Grierson JM Link B Lewellen, et al. 2005 Evaluation of 18F-annexin V as a PET imaging agent in an animal model of apoptosis J Nucl Med 46 4 658 666 15809489 1:CAS:528:DC%2BD2MXjvVyqtLY%3D
26. QD Nguyen G Smith M Glaser M Perumal E Arstad EO Aboagye 2009 Positron emission tomography imaging of drug-induced tumor apoptosis with a caspase-3/7 specific [18F]-labeled isatin sulfonamide Proc Natl Acad Sci U S A 106 38 16375 16380 19805307 10.1073/pnas.0901310106 1:CAS:528:DC%2BD1MXht1OjsbnE
27. D Zhou W Chu DL Chen Q Wang DE Reichert J Rothfuss, et al. 2009 [18F]- and [11C]-labeled N-benzyl-isatin sulfonamide analogues as PET tracers for apoptosis: synthesis, radiolabeling mechanism, and in vivo imaging study of apoptosis in Fas-treated mice using [11C]WC-98 Org Biomol Chem 7 7 1337 1348 19300818 10.1039/b819024k 1:CAS:528:DC%2BD1MXjtlOiu70%3D
28. Y Ariji N Fuwa T Kodaira H Tachibana T Nakamura Y Satoh, et al. 2009 False-positive positron emission tomography appearance with 18F- fluorodeoxyglucose after definitive radiotherapy for cancer of the mobile tongue Br J Radiol 82 973 e3 e7 19095811 10.1259/bjr/96087474 1:STN:280: DC%2BD1M%2FktVOltA%3D%3D
29. M Hentschel S Appold A Schreiber N Abolmaali A Abramyuk W Dorr, et al. 2011 Early FDG PET at 10 or 20 Gy under chemoradiotherapy is prognostic for locoregional control and overall survival in patients with head and neck cancer Eur J Nucl Med Mol Imaging 38 7 1203 1211 21350962 10.1007/s00259-011-1759-3